Executive Summary
Azoth Analytics has released a research report titled "Global Core Clinical Molecular Diagnostics Market (2023 Edition)" which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 11 countries (United States, Canada, United Kingdom, Germany, Italy, France, Spain, China, India, Japan, Australia). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
During the forecast period, 2024-2029, the Global Core Clinical Molecular Diagnostics market is expected to grow at a CAGR of 10.7%. The Global Core Clinical Molecular Diagnostics Market is expected to generate USD 11.04 billion by the end of 2029, up from USD 4.9 Billion in 2022.
Clinical Molecular diagnostics is a rapidly expanding market that encompasses a wide range of applications, including infectious illnesses, cancer, hematopathology, clinical chemistry, and clinical genetics. The increasing prevalence of chronic diseases coupled with the growing demand for advanced diagnostic solutions for early disease detection are driving the market growth.
Additionally, the increasing awareness of personalized treatment and direct-to-consumer genetic testing is also supporting the market growth.
Moreover, the rising global prevalence of infectious diseases has significantly contributed to the demand for clinical molecular diagnostics solutions, wherein polymerase chain reaction (PCR) testing has emerged as the primary method for detecting COVID-19. The application of polymerase chain reaction (PCR) testing has played a significant role in enhancing the field of molecular diagnostics for infectious diseases, specifically in nucleic acid-based methodologies. As a result, this particular segment has emerged as one of the most prominent segments within the core clinical molecular diagnostics market.
Scope of the Report:
- The report analyses the Core Clinical Molecular Diagnostics Market by Value (USD Billion).
- The report presents the analysis of Core Clinical Molecular Diagnostics Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
- The report analyses the Core Clinical Molecular Diagnostics Market by Application (Infectious disease and blood screening, Genetic testing, Cancer Screening Other Applications).
- The report analyses the Core Clinical Molecular Diagnostics Market by Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Other Technologies
- The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by Region, by Application & by Technologies.
- Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Merck Group (SigmaAldrich Co., LLC), F. Hoffmann-La Roche AG, Agilent technologies, PerkinElmer Inc., Abbott Laboratories, QIAGEN, Thermo Fisher Scientific, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation.
Global Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology (ISH, PCR, Sequencing, Others), By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
2.1 Integration of AI and Data Analytics to deliver highly accurate and rapid results
2.2 Partnerships with Academic Institutes
3. Global Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
3.1 Age-standardised cancer incidence rate, 2020*
3.2 SARS-Cov-2 Tests: Volumes 2020
3.3 Molecular diagnostics undergoing Clinical trials
3.4 Global Core Clinical Molecular Diagnostics Market: Dashboard
3.5 Global Core Clinical Molecular Diagnostics Market: Market Value Assessment, 2019-2029 (USD Billion)
3.6 Impact of COVID-19 on the Global Core Clinical Molecular Diagnostics Market
3.7 Global Core Clinical Molecular Diagnostics Market Segmentation: By Application
3.7.1 Global Core Clinical Molecular Diagnostics Market, By Application Overview
3.7.2 Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.3 Global Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.4 Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.5 Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
3.8 Global Core Clinical Molecular Diagnostics Market Segmentation: By Technology
3.8.1 Global Core Clinical Molecular Diagnostics Market, By Technology Overview
3.8.2 Global Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.3 Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.4 Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.5 Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
4. Global Core Clinical Molecular Diagnostics Market, Region Analysis
4.1 Regional Coverage of the Study
5. Americas Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
5.1 Americas Core Clinical Molecular Diagnostics Market: Snapshot
5.2 Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas Core Clinical Molecular Diagnostics Market: Key Factors
5.4 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Application
5.4.1 Americas Core Clinical Molecular Diagnostics Market, By Application Overview
5.4.2 Americas Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.3 Americas Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.4 Americas Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.5 Americas Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Technology
5.5.1 Americas Core Clinical Molecular Diagnostics Market, By Technology Overview
5.5.2 Americas Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Country
5.6.1 United States Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.1.1 United States Core Clinical Molecular Diagnostics Market, By Application
5.6.1.2 United States Core Clinical Molecular Diagnostics Market, By Technology
5.6.2 Canada Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.2.1 Canada Core Clinical Molecular Diagnostics Market, By Application
5.6.2.2 Canada Core Clinical Molecular Diagnostics Market, By Technology
5.6.3 Rest of Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.3.1 Rest of Americas Core Clinical Molecular Diagnostics Market, By Application
5.6.3.2 Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology
6. Europe Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
6.1 Europe Core Clinical Molecular Diagnostics Market: Snapshot
6.2 Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe Core Clinical Molecular Diagnostics Market: Key Factors
6.4 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Application
6.4.1 Europe Core Clinical Molecular Diagnostics Market, By Application Overview
6.4.2 Europe Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.3 Europe Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.4 Europe Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.5 Europe Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
6.5 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Technology
6.5.1 Europe Core Clinical Molecular Diagnostics Market, By Technology Overview
6.5.2 Europe Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.5 Europe Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Country
6.6.1 France Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.1.1 France Core Clinical Molecular Diagnostics Market, By Application
6.6.1.2 France Core Clinical Molecular Diagnostics Market, By Technology
6.6.2 United Kingdom Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 United Kingdom Core Clinical Molecular Diagnostics Market, By Application
6.6.2.2 United Kingdom Core Clinical Molecular Diagnostics Market, By Technology
6.6.2 Italy Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 Italy Core Clinical Molecular Diagnostics Market, By Application
6.6.2.2 Italy Core Clinical Molecular Diagnostics Market, By Technology
6.6.3 Spain Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.3.1 Spain Core Clinical Molecular Diagnostics Market, By Application
6.6.3.2 Spain Core Clinical Molecular Diagnostics Market, By Technology
6.6.4 Germany Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.4.1 Germany Core Clinical Molecular Diagnostics Market, By Application
6.6.4.2 Germany Core Clinical Molecular Diagnostics Market, By Technology
6.6.5 Rest of Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.5.1 Rest of Europe Core Clinical Molecular Diagnostics Market, By Application
6.6.5.2 Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology
7. Asia-Pacific Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
7.1 Asia-Pacific Core Clinical Molecular Diagnostics Market: Snapshot
7.2 Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia-Pacific Core Clinical Molecular Diagnostics Market: Key Factors
7.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Application
7.4.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application Overview
7.4.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
7.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Technology
7.5.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology Overview
7.5.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Country
7.6.1 China Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.1.1 China Core Clinical Molecular Diagnostics Market, By Application
7.6.1.2 China Core Clinical Molecular Diagnostics Market, By Technology
7.6.2 Japan Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.2.1 Japan Core Clinical Molecular Diagnostics Market, By Application
7.6.2.2 Japan Core Clinical Molecular Diagnostics Market, By Technology
7.6.3 India Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.3.1 India Core Clinical Molecular Diagnostics Market, By Application
7.6.3.2 India Core Clinical Molecular Diagnostics Market, By Technology
7.6.4 Australia Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.4.1 Australia Core Clinical Molecular Diagnostics Market, By Application
7.6.4.2 Australia Core Clinical Molecular Diagnostics Market, By Technology
7.6.5 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.5.1 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application
7.6.5.2 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology
8. Middle-East & Africa Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
8.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Snapshot
8.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Key Factors
8.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Application
8.4.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Application Overview
8.4.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Technology
8.5.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Technology Overview
8.5.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on Global Core Clinical Molecular Diagnostics Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Porter's Five Forces Analysis
10.1 Porter's Five Forces Model
11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Core Clinical Molecular Diagnostics Market
11.4 Company Profiles
11.4.1 Merck Group (SigmaAldrich Co., LLC)
11.4.2 F. Hoffmann-La Roche AG
11.4.3 Agilent technologies
11.4.4 PerkinElmer Inc.
11.4.5 Abbott Laboratories
11.4.6 QIAGEN
11.4.7 Thermo Fisher Scientific
11.4.8 Becton, Dickinson and Company
11.4.9 Hologic, Inc.
11.4.10 Danaher Corporation
List of Figures
Figure 1: Age-standardised cancer incidence rate, 2020*
Figure 2: Global Core Clinical Molecular Diagnostics Market Size, By Value, 2019-2022 (USD Billion)
Figure 3: Global Core Clinical Molecular Diagnostics Market Size, By Value, 2023-2029 (USD Billion)
Figure 4: Global Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 5: Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 6: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Infectious disease and blood screening, 2019-2029 (USD Billion)
Figure 7: Global Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 8: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Genetic testing, 2019-2029 (USD Billion)
Figure 9: Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 10: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Cancer Screening, 2019-2029 (USD Billion)
Figure 11: Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 12: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Other Applications, 2019-2029 (USD Billion)
Figure 13: Global Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 14: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By In situ hybridization, 2019-2029 (USD Billion)
Figure 15: Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 16: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Polymerase Chain Reaction, 2019-2029 (USD Billion)
Figure 17: Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 18: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Sequencing, 2019-2029 (USD Billion)
Figure 19: Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 20: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Others, 2019-2029 (USD Billion)
Figure 21: Americas Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 22: Americas Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 23: Americas Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 24: Americas Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 25: Americas Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 26: Americas Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: Americas Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 28: Americas Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 29: Americas Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 30: Americas Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 31: United States Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 32: United States Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 33: United States Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 34: United States Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 35: Canada Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 36: Canada Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 37: Canada Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 38: Canada Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 39: Rest of Americas Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 40: Rest of Americas Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 41: Rest of Americas Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 42: Rest of Americas Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 43: Europe Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 44: Europe Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 45: Europe Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 46: Europe Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 47: Europe Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 48: Europe Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 49: Europe Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 50: Europe Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 51: Europe Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 52: Europe Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 53: France Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 54: France Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 55: France Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 56: France Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 57: United Kingdom Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 58: United Kingdom Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 59: United Kingdom Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 60: United Kingdom Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 61: Italy Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 62: Italy Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 63: Italy Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 64: Italy Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 65: Spain Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 66: Spain Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 67: Spain Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 68: Spain Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 69: Germany Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 70: Germany Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 71: Germany Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 72: Germany Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 73: Rest of Europe Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 74: Rest of Europe Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 75: Rest of Europe Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 76: Rest of Europe Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 77: Asia Pacific Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 78: Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 79: Asia Pacific Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 80: Asia Pacific Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 81: Asia Pacific Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 82: Asia Pacific Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 83: Asia Pacific Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 84: Asia Pacific Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 85: Asia Pacific Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 86: Asia Pacific Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 87: China Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 88: China Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 89: China Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 90: China Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 91: Japan Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 92: Japan Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 93: Japan Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 94: Japan Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 95: India Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 96: India Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 97: India Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 98: India Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 99: Australia Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 100: Australia Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 101: Australia Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 102: Australia Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 103: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)
Figure 104: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)
Figure 105: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)
Figure 106: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)
Figure 107: Middle East and Africa Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)
Figure 108: Middle East and Africa Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)
Figure 109: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 110: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 111: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 112: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 113: Middle East and Africa Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 114: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 115: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 116: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 117: Global Impact of Drivers and Restraints
Figure 118: Market Share of Prominent Companies of Core Clinical Molecular diagnostics market, 2022 (%)
Figure 119: Merck Group Revenues, 2020-2022 (USD Million)
Figure 120: Merck Group Revenues, By Geographic Segments, 2022 (%)
Figure 121: Merck Group Revenue , By Business Segments, 2022 (%)
Figure 122: Roche Revenues, 2020-2022 (USD Million)
Figure 123: Roche Revenue , By Business Segment, 2022 (%)
Figure 124: Agilent technologies Revenues, 2020-2022 (USD Million)
Figure 125: Agilent technologies Revenue , By Geographic Segment, 2022 (%)
Figure 126: Agilent technologies Revenue , By Business Segment, 2022 (%)
Figure 127: Abbott Laboratories Revenues, 2020-2022 (USD Million)
Figure 128: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)
Figure 129: Abbott Laboratories Revenue , By Business Segments, 2022 (%)
Figure 130: Qiagen Revenues, 2020-2022 (USD Million)
Figure 131: Qiagen Revenue , By Customer class , 2022 (%)
Figure 132: Qiagen Revenue , By Geographical Segments, 2022 (%)
Figure 133: Thermo Fisher Revenues, 2020-2022 (USD Million)
Figure 134: Thermo Fisher Revenue , By Geographic segment, 2022 (%)
Figure 135: Thermo Fisher Revenue , By Business Segments, 2022 (%)
Figure 136: Becton, Dickinson and Company Revenues, 2020-2022 (USD Million)
Figure 137: Becton, Dickinson and Company Revenue , By Geographic segment, 2022 (%)
Figure 138: Becton, Dickinson and Company Revenue , By Business Segments, 2022 (%)
Figure 139: Hologic Revenues, 2020-2022 (USD Million)
Figure 140: Hologic Revenue , By Business Segment, 2022 (%)
Figure 141: Hologic Revenue , By Geographical Segments, 2022 (%)
Figure 142: Danaher Revenues, 2020-2022 (USD Million)
Figure 143: Danaher Revenue , By Business Segment, 2022 (%)
Figure 144: Danaher Revenues, By Geographical Segments, 2022 (%)
List of Tables
Table A1: SARS-Cov-2 Tests: Volumes 2020
Table A2: Molecular diagnostics undergoing Clinical trials
Table A3: United States Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A4: United States Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A5: United States Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A6: United States Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A7: Canada Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A8: Canada Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A9: Canada Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A10: Canada Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A11: Rest of Americas Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A12: Rest of Americas Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A13: Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A14: Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A15: France Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A16: France Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A17: France Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A18: France Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A19: United Kingdom Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A20: United Kingdom Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A21: United Kingdom Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A22: United Kingdom Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A23: Italy Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A24: Italy Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A25: Italy Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)
Table A26: Italy Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)
Table A27: Spain Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)
Table A28: Spain Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)
Table A29: Spain Core Clinical Molecular Diagnostics Market, By T
Molecular Diagnostics Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 400
Molecular Diagnostics Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the molecular diagnostics deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of molecular diagnostics deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics deals. These deals tend to be multicomponent, s......
Global Molecular Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 31-Oct-2023 Price: US 3380 Onwards Pages: 120
Market Overview of Global Molecular Diagnostic market:
According to our latest research, the global Molecular Diagnostic market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Molecular D......
Global Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology (ISH, PCR, Sequencing, Others), By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)
Published: 01-Oct-2023 Price: US 2450 Onwards Pages: 220
Executive Summary
Azoth Analytics has released a research report titled "Global Core Clinical Molecular Diagnostics Market (2023 Edition)" which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical p......
Global Molecular Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Sep-2023 Price: US 3380 Onwards Pages: 112
Market Overview of Global Molecular Diagnostics market:
According to our latest research, the global Molecular Diagnostics market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Molecular diagnosis refers to applying molecular biology methods to detect changes in the structure or expression level of genet......
Global Molecular Diagnostics in Infectious Disease Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 31-Aug-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global Molecular Diagnostics in Infectious Disease Testing market:
According to our latest research, the global Molecular Diagnostics in Infectious Disease Testing market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics in Infectious Disease Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time spa......
Global Molecular Diagnostics Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 114
Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes.
Market Analysis and Insights: Global Molecular Diagnost......
Global Molecular Diagnostics Market 2023
Published: 13-Aug-2023 Price: US 2450 Onwards Pages: 89
Description
According to the latest data, the market size of the global satellite imaging for agriculture sector is expected to rise by USD 234.5 million with a CAGR of 6.26% by the end of 2029. The implementation of satellite imaging in agriculture involves utilizing satellites to capture high-resolution images of agricultural land. These images offer valuable data and insights that can be leveraged to improve agricultural systems and enhance farming practices.
One of the key......
Global Molecular Diagnostics in Infectious Disease Testing Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 22-Jun-2023 Price: US 3260 Onwards Pages: 129
The Molecular Diagnostics in Infectious Disease Testing market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Molecular Diagnostics in Infectious Disease Testing industry, and breaks down according to the type, application, and consumption area of Molecular Diagnostics in Infectious Disease Testing. The report also introduces pla......
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Instruments, Software), Application (Respiratory Diseases, HAIs, Cancer, STDs, Hepatitis), Technology (RT-PCR, INAAT), End User (Clinics, Hospitals, ICUs) & Region - Global Forecast to 2028
Published: 14-Jun-2023 Price: US 4950 Onwards Pages: 212
“Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market”
The global point-of-care molecular diagnostics market size is projected to reach USD 3.4 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 10.6% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious dise......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
